---
document_datetime: 2025-05-23 19:15:07
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/pedmarqsi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: pedmarqsi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.2667627
conversion_datetime: 2025-12-28 09:06:33.14317
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Pedmarqsi

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, please also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                              | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | C.I HUMAN AND VETERINARY MEDICINAL | 22/05/2025                          |                                             | SmPC,                            |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000263648                     | PRODUCTS - C.I.z Other variation - Accepted C.I.z - to update sections 3, 4.2, 4.4, 4.5, 4.8, 5.1, 6.1, 10 of the SmPC to have the text harmonized with the core safety information (CCDS), including also editorial updates. Minor edits have been implemented in sections 3 and 4 of the Labelling and sections 2, 3 and 4 of the Package Leaflet were updated to enhance clarity and ensure consistency with the text as per CCDS. Moreover, additional editorial changes have been also implemented in BG, DA, EL, FR, HR, IT, PT, RO, SL and SV annexes.   |            |     | Labelling and PL   |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------|
| Variation type IA / EMA/VR/0000256830 | A.5 Change in the name and/or address of a manufacturer/importer of the finished product (including batch release or quality control testing sites) - A.5.b The activities for which the manufacturer/importer is responsible do not include batch release - Accepted                                                                                                                                                                                                                                                                                           | 24/03/2025 | N/A |                    |